Skip to main content
OpenTrials
Completed

NCT Number: NCT05410808

Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the Coronavirus Disease 2019 Pandemic

Fibromyalgia patients and controls living in the same household will be evaluated for levels of resilience, covid-19 related anxiety, coronavirus disease 2019 related obsession, quality of life and pain and comparisons and correlation analyses will be carried out.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fibromyalgia Anxiety Disorders COVID-19 Coronaviridae Infections Coronavirus Disease 2019 Pandemic Coronavirus Infections Infections Lung Diseases Mental Disorders Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neurologic Manifestations Neuromuscular Diseases Nidovirales Infections Pain Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Rheumatic Diseases Signs and Symptoms Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ege University School of Medicine

Bornova, İzmir, 35100, Turkey (Türkiye)

About this study

Fibromyalgia is a generalized pain condition that is accompanied by sleep disturbances, anxiety, depression and somatic symptoms. During Coronavirus disease 2019 pandemic, fibromyalgia patients as well as the general population have increased anxiety levels. This study was planned to evaluate fibromyalgia patients' levels of coronavirus disease 2019 related resilience, anxiety, obsession levels about coronavirus disease 2019, quality of life and pain levels and compare them with healthy controls living in the same household.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having a diagnosis of fibromyalgia according to the American college of rheumatology 2016 classification criteria
  • Older than 18 years of age

Exclusion criteria

  • Illiteracy
  • A history of coronavirus disease 2019 infection in the last month
  • Change in medication to treat fibromyalgia in the last 3 months
  • Living alone (lack of a control subject)
  • Severe neurological or psychiatric disorder that might hinder subjects' ability to answer the study questions

Treatment and study plan

Questionnaires and physical examination

Other

Patients will be examined and demographic data, disease characteristics will be recorded. Health Survey Questionnaire Short Form 36 , coronavirus disease 2019 anxiety scale ,Obsession with coronavirus disease 2019 scale, and Resilience scale for adults will be answered

Questionnaire

Other

Demographic data will be recorded. Health Survey Questionnaire Short Form 36 , coronavirus disease 2019 anxiety scale ,Obsession with coronavirus disease 2019 scale, and Resilience scale for adults will be answered

Primary outcomes

  1. Resilience

    Time frame: Day 1

    Immunity against traumatic life events, measured by resilience scale for adults

  2. Covid anxiety

    Time frame: Day 1

    Covid related anxiety levels, measured by covid-19 anxiety scale

  3. Obsession with covid-19

    Time frame: Day 1

    Obsession with covid-19, measured by obsession with covid scale

  4. Quality of life assessment

    Time frame: Day 1

    Measured by Health Survey Questionnaire Short Form 36

Sponsors and collaborators

Lead sponsor

Ege University

Other

Registry information

Official study title

Levels of Anxiety, Depression, and Quality of Life in Patients With Fibromyalgia During the COVID-19 Pandemic: A Cross-sectional Study

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jun 8, 2022
Registry last updated
Jan 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.